---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-24-000101"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:09:04.437159+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q2 diluted EPS $9.85 (+26% YoY); revenue $43.2B, down $0.2B

## Summary
- Adjusted diluted EPS $10.12 (+12% YoY); GAAP EPS at least $34.05 for FY2024, adjusted at least $37.20.
- Health Benefits revenue $37.2B (-2%); Carelon revenue $13.3B (+10%) on risk-based service growth.
- Medical membership 45.8M, down 5% YoY due to Medicaid redeterminations; partly offset by ACA growth.
- Benefit expense ratio improved 10 bps to 86.3%; operating expense ratio increased to 11.7%.
- Q3 dividend $1.63/share declared, payable Sept 25, 2024; $3.2B share repurchase authorization remaining.

## SEC filing metadata
- accession: 0001156039-24-000101
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000101/0001156039-24-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000101/elv-20240717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-24-000101
- JSON: https://secwatch.observer/filing/0001156039-24-000101.json
- Plain text: https://secwatch.observer/filing/0001156039-24-000101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.